Medical Innovation Exchange

Emalex wants to fill gaps in 'exceptionally difficult' Tourette syndrome with massive $250M raise

https://www.fiercebiotech.com/biotech/tourette-focused-emalex-rakes-250m-series-d-funding-7x-larger-its-series-c

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!